麦澜德股价涨5.04%，华夏基金旗下1只基金位居十大流通股东，持有70.15万股浮盈赚取126.28万元

Group 1 - The core viewpoint of the news is that 麦澜德 (Milan Medical Technology Co., Ltd.) has seen a stock price increase of 5.04%, reaching 37.52 CNY per share, with a total market capitalization of 3.752 billion CNY as of the report date [1] - The company, established on January 16, 2013, and listed on August 11, 2022, specializes in the research, production, sales, and services related to pelvic floor and postpartum rehabilitation products [1] - The revenue composition of the company includes pelvic rehabilitation products (36.98%), reproductive rehabilitation products (33.10%), consumables and accessories (24.32%), sports rehabilitation products (2.77%), and other products (2.84%) [1] Group 2 - Among the top circulating shareholders of 麦澜德, 华夏稳增混合 (Huaxia Stable Growth Mixed Fund) reduced its holdings by 550,500 shares in the third quarter, now holding 701,500 shares, which accounts for 1.9% of the circulating shares [2] - The fund has achieved a year-to-date return of 36.83% and a one-year return of 32.03%, ranking 1759 out of 8199 and 2264 out of 8131 in its category, respectively [2] - The fund manager, 彭海伟 (Peng Haiwei), has a tenure of 11 years and 322 days, with the fund's total asset size at 1.314 billion CNY [3]